Pharma's Digital Leap

Q1. Could you start by giving us a brief overview of your professional background, particularly focusing on your expertise in the industry?

I have a broad background that includes work in the pharmaceutical, FMCG, and chemical industries. I began my career in the chemical business before moving into the fast-moving consumer goods (FMCG) sector, where I gained solid experience in supply chain dynamics, production procedures, and product development. Over the years, I transitioned into the pharmaceutical space, where I’ve been focusing more intensively on the manufacturing of drugs, including sterile and non-sterile tropical products, as well as business dynamics. My experience across these industries has given me a comprehensive understanding of both fast-moving product cycles and the stringent quality and regulatory requirements of pharma, allowing me to bring a unique, cross-functional perspective to problem-solving and strategy execution.”

Q2. How is the adoption of Industry 4.0 and digital manufacturing evolving in the pharma sector?

The adoption of Industry 4.0 and digital manufacturing in the pharmaceutical sector is accelerating, though unevenly across regions and company sizes. Here’s a structured view of how it’s evolving

Drivers of Adoption

• Regulatory Pressure: Agencies like the FDA and EMA are encouraging data integrity, real-time monitoring (e.g.,…